← Back to catalogue
Research draft

hemangioma

vr.tr.hemangioma · PHY.LIV

Let an agent explain haemangiomas and their course in general terms, distinguish them from vascular malformations and other marks, relay guidance on when assessment is advised from paediatric and dermatology sources, and route personal cases to clinicians.

Thing Registry Physical world and living systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain haemangiomas and their course in general terms, distinguish them from vascular malformations and other marks, relay guidance on when assessment is advised from paediatric and dermatology sources, and route personal cases to clinicians.

A benign tumour made of blood vessels, most often the infantile haemangioma that appears in the first weeks of life as a raised red mark, grows for months and then shrinks over years, usually without treatment; other haemangiomas occur in the liver, skin and elsewhere, and vascular malformations, which are structural anomalies rather than tumours, are a related but distinct group.

What it is for: Not applicable; a benign growth.

It can be explain kinds and typical course; distinguish haemangiomas from malformations; relay guidance on assessment and treatment in general terms; route personal cases to clinicians.

Distinguishing features

Benign vascular tumour

Growth then involution in infants

Distinct from malformations

Usually needs no treatment

What it looks like

A raised, bright red or bluish mark on the skin in infants, or an internal lesion seen on imaging.

Physical character

infantile haemangioma incidence: about 4-5 percent of infants - estimates vary

involution: over several years - most regress by school age

How it is recognised

Benign blood vessel tumour

Infantile form grows then shrinks

Port-wine stains and arteriovenous malformations are malformations, not haemangiomas

Related models

is a kind of - a benign tumour

benign neoplasm

is a kind of - made of blood vessels

vascular neoplasm

is confused with - a structural anomaly

vascular malformation

is treated by - and paediatrics

dermatology

In practice

Families and kinds

infantile haemangioma

congenital haemangioma

liver haemangioma in adults

cherry angioma and other acquired vascular lesions

vascular malformations as a related but distinct group

Identifiers

ICD-10 D18.0 haemangioma any site

ICD-11 2E81

Standards and regulation

Clinical guidelines on infantile haemangioma management

ISSVA classification of vascular anomalies

Failure modes and hazards

Ulceration, bleeding or obstruction in some sites

Misclassification as a malformation

Agents giving personal medical advice

Also called

skin epithelioid hemangiomaCobb syndromebreast hemangiomaVein of Galen aneurysmal malformationscerebral arteriovenous malformationhemangioblastomaintramuscular hemangiomaintracranial structure hemangiomasclerosing hemangiomalittoral cell angiomaarteriovenous malformationhemangioma of orbithemangioma of intra-abdominal structurevenous hemangiomadeep angiomaskin hemangiomasubglottic angiomahistiocytoid hemangiomahemangioma of peripheral nervehemangioma of lungacquired hemangiomacentral nervous system hemangiomabrain angiomapulmonary sclerosing hemangiomaspindle cell hemangiomaChorioangiomachorioangiomaglomeruloid hemangiomahemangioma of retinahemangioma of choroidhemangioma of gingivahemangioendotheliomahemangiomatosisKasabach-Merritt syndrometargetoid hemosiderotic hemangiomabenign deep fibrous histiocytomacentral nervous system hemangioblastomavein of Galen malformationsBonnet–Dechaume–Blanc syndromekaposiform hemangioendothelioma

+15

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Understand What a haemangioma is.

General information.

Kinds

Kinds and course.

Kinds

Kinds.

  1. What kinds of haemangioma exist, and what is the typical course of the infantile form? definition
  2. Is the user asking about their own child or themselves, which needs a clinician? boundary

Distinguish

Malformations and other marks.

Distinguish

Distinguish.

  1. How are haemangiomas distinguished from vascular malformations and other birthmarks? definition
  2. Which entry fits vascular malformations? action
Assess Assessment.

Clinical.

When

When to assess.

When

When.

  1. When do guidelines advise assessment, such as for size, site or ulceration? provenance
  2. Which entry fits paediatric dermatology? action

Diagnosis

Diagnosis.

Diagnosis

Diagnosis.

  1. How are haemangiomas diagnosed, in general terms? provenance
  2. Which methods are standard? provenance
Manage Management.

Care.

Treatment

Treatment.

Treatment

Treatment.

  1. What treatments do guidelines describe when needed, in general terms? provenance
  2. Is the presentation free of personal treatment advice? boundary

Support

Support.

Support

Support.

  1. What support exists for families? provenance
  2. Which entry fits patient support? action
Study Research and teaching.

Study.

Research

Research.

Research

Research.

  1. What is known about causes and mechanisms, with findings attributed? provenance
  2. Which references are standard? provenance

Teach

Teaching.

Teach

Teaching.

  1. How are vascular anomalies taught and classified? action
  2. Which misconceptions arise? provenance

What the second pass must settle

  • Should infantile haemangioma be a separate entry?
  • How should classification and guidelines be linked?
  • The registry entry has merged aliases for malformations and other tumours; should they be split off?